Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience
2019
Background
Teriflunomide(TRF) and
Dimethyl fumarate(DMF) are licensed drugs for relapsing-remitting
Multiple Sclerosis(RRMS).
Keywords:
-
Correction
-
Source
-
Cite
-
Save
20
References
14
Citations
NaN
KQI